Amplification Curve Analysis for Matrix-Inhibited Assay Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Traditional methods for detecting pathogens in food, feed, and water samples are time-consuming and prone to false negatives due to matrix inhibition, which occurs when substances in the sample interfere with nucleic acid amplification assays like PCR and LAMP, leading to inaccurate results.

Innovation Solution

A system using machine learning to analyze data from nucleic acid amplification assays, distinguishing between true and false negative results by training on data sets with known inhibitors, thereby reducing the need for internal or external amplification controls.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Speed

If traditional nucleic acid amplification assays are used to detect pathogens, then the detection speed is improved, but false negative results increase due to matrix inhibition

Engineering Contradiction:
Improvedetection speedVSAvoiddetection accuracy
Core Design Contradiction:
SpeedVSReliability

Solution Approach 1:

The system continuously monitors the amplification reaction and uses machine learning algorithms to analyze signal patterns in real-time, providing feedback to distinguish between true negatives and inhibited reactions. The machine learning model processes multiple parameters (slope, area under curve, threshold crossings) to determine whether inhibition is occurring, allowing the system to correct false negative results while maintaining fast detection speeds.

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The patent replaces traditional mechanical or manual verification methods with an automated machine learning-based detection system. Instead of relying on manual review or additional control reactions, the system uses computational algorithms to analyze amplification curves and automatically identify inhibited samples, improving both speed and accuracy.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Reliability

If internal or external amplification controls are added to detect inhibition, then detection accuracy is improved, but device complexity increases

Engineering Contradiction:
Improvedetection accuracyVSAvoidassay complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The system uses the amplification reaction itself to provide diagnostic information about inhibition status. By analyzing the signal characteristics of the target nucleic acid amplification curve, the machine learning model automatically determines whether inhibition is present, eliminating the need for separate control reactions or additional reagents. The assay serves its own diagnostic function through computational analysis.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The machine learning system performs multiple functions simultaneously: it detects the target pathogen, quantifies the nucleic acid amount, and identifies inhibition status all within a single amplification reaction. This multi-functionality eliminates the need for separate control assays, reducing overall system complexity while improving detection accuracy.

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Reliability

If multiple parameters are monitored during amplification, then false negative detection is reduced, but data processing complexity increases

Engineering Contradiction:
Improvefalse negative reductionVSAvoiddata processing complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent replaces manual multi-parameter analysis with automated machine learning algorithms that process multiple parameters simultaneously. The machine learning model integrates signals from various amplification curve characteristics (slope, area, threshold crossings, baseline deviations) into a unified inhibition determination, reducing the burden on operators while improving detection reliability.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The system creates a digital representation of the amplification reaction through machine learning models that capture the essential features of the signal patterns. By training on known inhibited and non-inhibited samples, the model creates a computational copy that can quickly and accurately identify inhibition without requiring complex manual analysis of multiple parameters.

Inventive Principle:
Principle #26Copying

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Improves the accuracy of pathogen detection and quantification by reducing false-negative results, enhancing the effectiveness of pathogen-intervention processes in food production.

Implementation Method 1

a reaction chamber configured to receive a sample comprising a matrix and a quantity of the target nucleic acid and to amplify the target nucleic acid within the sample over a nucleic acid amplification cycle

Methodology Applied
Scientific EffectNucleic acid amplification:

Implementation Method 2

a detector, the detector configured to capture, during the nucleic acid amplification cycle, measurements representative of a quantity of the target nucleic acid present in the sample

Methodology Applied
Scientific EffectFluorescence detection: Fluorescence

Data Source

PatentUS12584164B2System and method for detecting inhibition of a biological assay
Publication Date: 2026.03.24 NEOGEN FOOD SAFETY US HOLDCO CORP
  • US12584164B2 patent drawing
  • US12584164B2 patent drawing
  • US12584164B2 patent drawing

AI summary

In some examples, a system for detecting inhibition of a biological assay includes a detection device configured to amplify and detect a target nucleic acid. The detection device is configured to receive a sample comprising a matrix and a quantity of the target nucleic acid and to amplify the target nucleic acid within the sample over a nucleic acid amplification cycle. The detection device is configured to capture a data set including measurements of the nucleic acid collected during the amplification cycle. The system further includes a computing device configured to receive the data set and to apply a machine-learning system to the data set to detect inhibited biological assays that tested negative for the target nucleic acid due to matrix inhibition.